Jyong Biotech Ltd. Ordinary Shares

MENS | NASDAQ

$1.91

+$0.03 (+1.60%)

Nov 2, 2026, 1:57 PM ET · Market open

Fiscal Quarter Period Ending	Q4 2025 Dec 31, 2025	Q3 2025 Sep 30, 2025	Q2 2025 Jun 30, 2025	Q4 2024 Dec 31, 2024	Q3 2024 Sep 30, 2024	Q2 2024 Jun 30, 2024	Q1 2024 Mar 31, 2024	Q4 2023 Dec 31, 2023
Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	n/a	n/a	n/a	58K	n/a	62K	n/a	n/a
Gross Profit	n/a	n/a	n/a	-58K	n/a	-62K	n/a	n/a
Operating Income	-1.79M	-895.50	-816K	-552.50	-552.50	-475.50	-475.50	-844
Interest Income	586K	n/a	24K	1K	n/a	6K	n/a	n/a
Pretax Income	-3.42M	-1.71K	-1.25M	-846.50	-846.50	-663	-663	-1.33K
Net Income	-3.42M	-1.71K	-1.25M	-846.50	-846.50	-663	-663	-1.33K
Selling & General & Admin	1.35M	672.50	449K	338.50	338.50	226	226	577.50
Research & Development	446K	223	367K	214	214	249.50	249.50	266.50
Other Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Expenses	1.79M	895.50	816K	552.50	552.50	475.50	475.50	844
Interest Expense	2.12M	768	417K	587K	293	448K	221	172
Selling & Marketing Expenses	n/a	12.50	n/a	11.50	11.50	10.50	10.50	12.50
Cost & Expenses	1.79M	895.50	816K	552.50	552.50	475.50	475.50	844
Income Tax Expense	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Shares Outstanding (Basic)	74.23M	74.26K	71.76M	71.57K	71.57K	71.57K	71.57K	71.57K
Shares Outstanding (Diluted)	74.23M	74.26K	71.76M	71.57K	71.57K	71.57K	71.57K	71.57K
EPS (Basic)	-0.05	-0.02	-0.02	-0.01	-0.01	-0.01	-0.01	-0.02
EPS (Diluted)	-0.05	-0.02	-0.02	-0.01	-0.01	-0.01	-0.01	-0.02
EBITDA	-1.79M	-865.50	-835K	-523.50	-523.50	-444.50	-444.50	-813
EBIT	-1.79M	-895.50	-835K	-552.50	-552.50	-475.50	-475.50	-844
Depreciation & Amortization	n/a	30	n/a	29	29	31	31	31